tiprankstipranks
HCW Biologics (HCWB)
NASDAQ:HCWB
US Market

HCW Biologics (HCWB) Financial Statements

24 Followers

HCW Biologics Financial Overview

HCW Biologics's market cap is currently ―. The company's EPS TTM is $-0.754; its P/E ratio is -0.85; HCW Biologics is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.13M$ 853.10K$ 622.81K-$ 1.35M
Gross Profit$ 614.75K$ 174.78K$ 622.81K$ -29.35K$ 268.30K
EBIT$ -7.47M$ -4.16M$ -4.21M$ -4.98M$ -5.36M
EBITDA$ -7.22M$ -3.89M$ -3.92M$ -4.68M$ -5.10M
Net Income Common Stockholders$ -7.47M$ -4.94M$ -4.30M$ -5.07M$ -5.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.08M$ 11.22M$ 17.41M$ 28.24M$ 32.06M
Total Assets$ 30.43M$ 35.62M$ 39.48M$ 43.53M$ 46.81M
Total Debt$ 8.27M$ 6.33M$ 6.36M$ 6.39M$ 6.41M
Net Debt$ 4.19M$ -4.89M$ -11.05M$ -21.85M$ -25.65M
Total Liabilities$ 21.69M$ 11.75M$ 10.90M$ 10.92M$ 9.38M
Stockholders Equity$ 8.74M$ 23.87M$ 28.59M$ 32.62M$ 37.43M
Cash Flow-
Free Cash Flow$ -3.73M$ -6.22M$ -10.95M$ -3.94M$ -3.86M
Operating Cash Flow$ -3.60M$ -5.59M$ -9.39M$ -3.64M$ -3.79M
Investing Cash Flow$ -129.71K$ 9.37M$ -1.56M$ -300.38K$ -68.69K
Financing Cash Flow$ 4.22M$ -8.90K$ 7.71K$ 1.90K$ -39.85K
Currency in USD

HCW Biologics Earnings and Revenue History

HCW Biologics Debt to Assets

HCW Biologics Cash Flow

HCW Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis